A detailed history of Inves Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Inves Trust holds 41,319 shares of BMY stock, worth $1.93 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
41,319
Previous 40,984 0.82%
Holding current value
$1.93 Million
Previous $1.9 Billion 1.77%
% of portfolio
0.68%
Previous 0.73%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 02, 2025

BUY
$43.31 - $48.98 $14,508 - $16,408
335 Added 0.82%
41,319 $1.86 Billion
Q2 2025

Jul 02, 2025

SELL
$44.12 - $59.6 $3.27 Million - $4.42 Million
-74,178 Reduced 64.41%
40,984 $1.9 Billion
Q1 2025

Apr 09, 2025

BUY
$53.9 - $63.11 $27,650 - $32,375
513 Added 0.45%
115,162 $7.02 Billion
Q4 2024

Jan 08, 2025

BUY
$51.92 - $59.94 $5.95 Million - $6.87 Million
114,649 New
114,649 $6.47 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Inves Trust Portfolio

Follow Inves Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inves Trust, based on Form 13F filings with the SEC.

News

Stay updated on Inves Trust with notifications on news.